A detailed history of North Star Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, North Star Asset Management Inc holds 305,320 shares of ABT stock, worth $35.4 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
305,320
Previous 299,990 1.78%
Holding current value
$35.4 Million
Previous $31.2 Million 11.67%
% of portfolio
1.63%
Previous 1.54%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $533,373 - $629,632
5,330 Added 1.78%
305,320 $34.8 Million
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $623,820 - $696,340
6,193 Added 2.11%
299,990 $31.2 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $170,632 - $188,455
1,558 Added 0.53%
293,797 $33.4 Million
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $590,834 - $723,230
6,551 Added 2.29%
292,239 $32.2 Million
Q3 2023

Oct 26, 2023

BUY
$95.53 - $114.62 $594,865 - $713,738
6,227 Added 2.23%
285,688 $27.7 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $378,428 - $421,648
3,755 Added 1.36%
279,461 $30.5 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $1.39 Million - $1.63 Million
14,328 Added 5.48%
275,706 $27.9 Million
Q4 2022

Mar 06, 2023

BUY
$95.06 - $111.52 $214,360 - $251,477
2,255 Added 0.87%
261,378 $28.7 Million
Q3 2022

Nov 08, 2022

BUY
$96.76 - $112.03 $386,556 - $447,559
3,995 Added 1.57%
259,123 $25.1 Million
Q2 2022

Jul 28, 2022

BUY
$102.07 - $123.37 $29,294 - $35,407
287 Added 0.11%
255,128 $27.7 Million
Q1 2022

Apr 29, 2022

SELL
$114.02 - $139.04 $273,077 - $333,000
-2,395 Reduced 0.93%
254,841 $30.2 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $123,848 - $151,645
1,072 Added 0.42%
257,236 $36.2 Million
Q3 2021

Oct 20, 2021

BUY
$116.66 - $129.06 $406,093 - $449,257
3,481 Added 1.38%
256,164 $30.3 Million
Q2 2021

Jul 30, 2021

BUY
$105.79 - $124.53 $300,337 - $353,540
2,839 Added 1.14%
252,683 $29.3 Million
Q1 2021

Apr 29, 2021

SELL
$108.84 - $128.23 $142,906 - $168,365
-1,313 Reduced 0.52%
249,844 $29.9 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $75,810 - $82,611
-722 Reduced 0.29%
251,157 $27.5 Million
Q3 2020

Nov 02, 2020

SELL
$91.64 - $111.29 $272,537 - $330,976
-2,974 Reduced 1.17%
251,879 $27.4 Million
Q2 2020

Jul 28, 2020

SELL
$76.57 - $98.0 $518,072 - $663,068
-6,766 Reduced 2.59%
254,853 $23.3 Million
Q1 2020

Apr 24, 2020

SELL
$62.82 - $91.86 $185,004 - $270,527
-2,945 Reduced 1.11%
261,619 $20.6 Million
Q4 2019

Feb 06, 2020

SELL
$78.51 - $87.4 $69,716 - $77,611
-888 Reduced 0.33%
264,564 $23 Million
Q3 2019

Oct 25, 2019

SELL
$81.84 - $88.74 $425,977 - $461,891
-5,205 Reduced 1.92%
265,452 $22.2 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $33,889 - $39,525
-465 Reduced 0.17%
270,657 $22.8 Million
Q1 2019

Apr 26, 2019

SELL
$66.22 - $80.06 $186,078 - $224,968
-2,810 Reduced 1.03%
271,122 $21.7 Million
Q4 2018

Jan 29, 2019

SELL
$65.56 - $74.27 $29,239 - $33,124
-446 Reduced 0.16%
273,932 $19.8 Million
Q3 2018

Oct 29, 2018

SELL
$60.81 - $73.36 $73,884 - $89,132
-1,215 Reduced 0.44%
274,378 $20.1 Million
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $47,667 - $52,611
828 Added 0.3%
275,593 $16.8 Million
Q1 2018

Apr 27, 2018

SELL
$56.27 - $63.62 $92,845 - $104,973
-1,650 Reduced 0.6%
274,765 $16.5 Million
Q4 2017

Feb 01, 2018

BUY
$53.68 - $57.47 $1.09 Million - $1.17 Million
20,381 Added 7.96%
276,415 $15.8 Million
Q3 2017

Oct 25, 2017

BUY
$48.06 - $53.64 $229,005 - $255,594
4,765 Added 1.9%
256,034 $13.7 Million
Q3 2017

Oct 25, 2017

SELL
$48.06 - $53.64 $419,563 - $468,277
-8,730 Reduced 3.36%
251,269 $11.2 Million
Q2 2017

Aug 16, 2017

BUY
N/A
259,999
259,999 $12.6 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.